In AP models, NLRP3 activation in acinar and immune cells drives cleavage of pro-IL-1β and pro-IL-18, neutrophil influx, and tissue injury; genetic or pharmacologic attenuation of NLRP3 reduces pancreatic necro-inflammation and lung injury [46,47,48]. The gene discussed is IL1B; the disease is alkaline phosphatase measurement.